Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Recruiting
Observational Study
MASLD
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
NAFLD
NAFLD (Nonalcoholic Fatty Liver Disease)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 26 (estimated)
- Sponsor
- University of California, San Diego · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a new technology to evaluate the liver (LiverScope®). We will compare LiverScope® to other methods to evaluate the liver, including advanced conventional liver MR exams. MR exams are common exams used to monitor MASLD (also…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Known or clinically suspected MASLD
* BMI greater than 27 kg/m\^2 and less than 45 kg/m\^2 at the time of referral
* Ability to lie on LiverScope® device table for about 60 minutes
* Ability to hold breath repeatedly for about 20 seconds during MR and LiverSco…
Contacts